The Strategic Advisory Group on Monkeypox, chaired by the Chief Medical Officer, advises the Department of Health and the Government on how best to respond to the outbreak. It reviews evidence and advises as appropriate on monkeypox surveillance and management at a national level; development and implementation of a strategy to control monkeypox; and provides oversight and assurance of the national response.
The Group’s membership includes experts from multiple disciplines including public health, infectious diseases and immunology fields. It builds on the significant work already undertaken by the HSE and the ongoing work of the HSE’s National Crisis Management Team. Membership of the Group is kept under review to ensure representation at a point in time is reflective of the work underway.